Arch Therapeutics, Inc. Annual Operating Margin in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Arch Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2021 to 2023.
  • Arch Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -3.19K %, a 76.7% increase year-over-year.
  • Arch Therapeutics, Inc. annual Operating Margin for 2023 was -6.66K %, a 81.7% increase from 2022.
  • Arch Therapeutics, Inc. annual Operating Margin for 2022 was -36.5K %, a 33.9% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -6.66K +29.8K +81.7% Oct 1, 2022 Sep 30, 2023
2022 -36.5K +18.7K +33.9% Oct 1, 2021 Sep 30, 2022
2021 -55.1K Oct 1, 2020 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.